ramucirumab,pembrolizumab
eli lilly,merck
['s1800a', 'sclc', 'nsclc']
s1800a presented today at #asco22 by dr . check out our editorial on positive os with the combination of pembro + ram versus chemo in patients with nsclc who experienced disease progression on prior io. 
Medical Thoracic Oncology, Clinical trials, lung cancer